After a three-year effort, scientists have determined the crystal structure of edema factor, a toxic protein secreted by Bacillus anthracis, the bacteria that causes anthrax.1 Edema factor (EF) works ...

WHAT IS ANTHRAX? Bacillus anthracis is a rod-shaped bacterium that typically appears–when outside a living host–in a dormant state, protected by a hard-shelled spore. Provided it is lodged in rich ...

In October 2001, letters containing virulent anthrax bacteria were sent through the U.S. mail. Between October 4 and November 20, 2001, 22 individuals developed anthrax and 5 of these cases were fatal ...

The study of the B. thuringiensis spray in Canada in 1999 provides data that refutes arguments asserting that there are technological barriers that would prevent all but major military programs from ...

With the emergence of multi-drug resistant (MDR) “super bugs” the need for new bactericidal approaches is growing in urgency. Compounding the threat of MDR, is the rise of antibiotic resistance in ...

Bacillus anthracis, the causative agent of anthrax, possesses a uniquely complex cell envelope that is critical to its pathogenicity. Central to its virulence are the secondary cell wall ...

ALBUQUERQUE, N.M. — A credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories and recently licensed to a small business makes testing safer, easier, faster and cheaper.

Anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it, according to a new study published in Microbiology. The work could ...

Given the possible severity of anthrax infection, early and fast diagnosis is key. InBios International, Inc., a developer of diagnostic tests for emerging infectious diseases and biothreats, has been ...

STATEN ISLAND, N.Y., Sept. 26, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small ...